Benefit and risk in tissue engineering

Materials Today

Volumn 7, Issue 5, 2004, Pages 24-29

  Williams, David ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCOMPATIBILITY; BLOOD; CELL CULTURE; DISEASES; GENES; MICROBIOLOGY; NUTRITION; PATIENT TREATMENT; SKIN; TISSUE;

CELL EXPANSION; GENE THERAPY; GENE TRANSFECTION; PHENOTYPES; TISSUE ENGINEERING;

GENETIC ENGINEERING;

EID: 1942451976     PISSN: 13697021     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1369-7021(04)00232-9     Document Type: Article

References (16)

1. Williams D.F. The Williams Dictionary of Biomaterials. 1999;Liverpool University Press, Liverpool.
2. Dobbelstein M. Virus Res. 92:(2):2003;219.
3. Falabella A.F., , et al. Arch. Dermatol. 136:(10):2000;1225.
4. Guidance on the selection of prostheses for primary hip replacement, 2, National Institute for Clinical Excellence ( www.nice.org.uk ), UK,(2000).
5. Schlosshauer B., et al. Brain Res. 963:(1-2):2003;321.
6. Cleland J.G.F., , et al. Eur. J. Heart Failure. 5:(3):2003;295.
7. Shimizu T., , et al. Biomaterials. 24:(13):2003;2309.
8. Cloned human embryos are stem cell breakthrough, New Scientist, Feb 12, 2004.
9. Kolettas E., , et al. Rheumatology. 40:(10):2001;1146.
10. Ingber D.E. Ann. Med. 35:(8):2003;564.
11. Engelmayr G.C. Jr., , et al. Biomaterials. 24:(14):2003;2523.
12. Zisch A.H., , et al. Cardiovasc. Pathol. 12:(6):2003;295.
13. Kirkpatrick C.J., , et al. Biomol. Eng. 19:(2-6):2002;211.
14. Scientific Committee on Medicinal Products and Medical Devices. Opinion on the State of the Art Concerning Tissue Engineering. 2001;European Union.
15. Williams, D. F., Presented at The University of Washington Summer Symposium on Redefining Biocompatibility, Seattle, WA, 2003.
16. Williams D.F. The Geneva Papers on Risk and Insurance. 28:2003;331.